A study by the Barcelona Public Health Agency has revealed those sections of the population that are most vulnerable to tuberculosis. The research, published in the journal Respiratory Research, shows that the highest death rates from this disease are among those aged over 50 or infected with HIV.
"Some patients give up their tuberculosis treatment (which lasts for a minimum of six months), resulting in a danger of them infecting other people, worsening their own state of health or even dying," says Joan A. Caylà, lead author of the study and a researcher at the Barcelona Public Health Agency (ASPB).
The study identifies the factors linked to people giving up tuberculosis treatment and deaths from the disease. Researchers from the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) analyzed a sample of 1,490 people with the illness in Spain between 2006 and 2007.
The results of these studies show that abandoning tuberculosis treatment is usually related to having undergone previous treatment for the disease, being an injecting drug user (IDU), living with a large number of people, and also the doctor's perception that the patient does not have a good understanding of the treatment.
The authors from the ASPB, meanwhile, stress that deaths are associated with failure to understand the treatment, being an IDU, being in directly-observed treatment (DOT), and also being over the age of 50 or being infected with HIV.
The World Health Organization (WHO) declared 24 March as World TB Day, to commemorate the day in 1882 when the biomedic Robert Koch announced the discovery of the bacillus that causes the disease. This was the first step towards being able to diagnose and cure it.
Each year, eight million people contract tuberculosis worldwide, and two million die from it. Although tuberculosis is still endemic in Spain and other wealthy countries, there has been a resurgence of tuberculosis infections in some rural areas, and with the increase in HIV and failure to control the disease.
The WHO aims for the tuberculosis prevalence and death rates to have fallen to half their current levels by 2015. Today, around 2 billion people – one-third of the entire world population – are infected with tuberculosis.
Reference: Caylà JA, Rodrigo T, Ruiz-Manzano J, Caminero JA, Vidal R, García JM, Blanquer R, Casals M and the Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE). "Tuberculosis treatment adherence and fatality in Spain". Respiratory Research, 10:121, diciembre de 2009.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.